Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda M Termuhlen

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 12, 2017
Natural killer/T-cell lymphomas in pediatric and adolescent patientsAmanda M Termuhlen
Journal of Pediatric Hematology/Oncology|October 12, 2005
Once in a lifetimeAmanda M Termuhlen, Thomas G Gross
Current Hematologic Malignancy Reports|April 29, 2010
Pediatric non-Hodgkin lymphomaThomas G Gross, Amanda M Termuhlen
Current Oncology Reports|November 10, 2007
Pediatric non-Hodgkin's lymphomaThomas G Gross, Amanda M Termuhlen
Current Hematologic Malignancy Reports|May 22, 2010
Rare pediatric non-hodgkin lymphomaBhuvana A Setty, Amanda M Termuhlen
Pediatric Blood & Cancer|December 17, 2004
Mucoepidermoid carcinoma of the parotid gland as a second malignant neoplasmStephanie L Savelli, Kathryn J Klopfenstein, Amanda M Termuhlen
British Journal of Haematology|January 8, 2019
Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B-cell non-Hodgkin lymphomaYaya Chu, Aliza Gardenswartz, Amanda M Termuhlen, et al.
The Journal of Pediatrics|March 1, 2011
Venous thromboembolism and adolescent and young adult oncology inpatients in US children's hospitals, 2001 to 2008Sarah H O'Brien, Jennifer Klima, Amanda M Termuhlen, et al.
Seminars in Oncology|October 20, 2009
Lymphoma in adolescents and young adultsSamantha M Jaglowski, Erica Linden, Amanda M Termuhlen, et al.
Pediatric Transplantation|October 13, 2006
Autologous hematopoietic stem cell transplant with melphalan and thiotepa is safe and feasible in pediatric patients with low normalized glomerular filtration rateAmanda M Termuhlen, Alfred Grovas, Kathryn Klopfenstein, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|April 12, 2017
Natural killer/T-cell lymphomas in pediatric and adolescent patientsAmanda M Termuhlen
Journal of Pediatric Hematology/Oncology|October 12, 2005
Once in a lifetimeAmanda M Termuhlen, Thomas G Gross
Current Hematologic Malignancy Reports|April 29, 2010
Pediatric non-Hodgkin lymphomaThomas G Gross, Amanda M Termuhlen
Current Oncology Reports|November 10, 2007
Pediatric non-Hodgkin's lymphomaThomas G Gross, Amanda M Termuhlen
Current Hematologic Malignancy Reports|May 22, 2010
Rare pediatric non-hodgkin lymphomaBhuvana A Setty, Amanda M Termuhlen
Pediatric Blood & Cancer|December 17, 2004
Mucoepidermoid carcinoma of the parotid gland as a second malignant neoplasmStephanie L Savelli, Kathryn J Klopfenstein, Amanda M Termuhlen
British Journal of Haematology|January 8, 2019
Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B-cell non-Hodgkin lymphomaYaya Chu, Aliza Gardenswartz, Amanda M Termuhlen, et al.
The Journal of Pediatrics|March 1, 2011
Venous thromboembolism and adolescent and young adult oncology inpatients in US children's hospitals, 2001 to 2008Sarah H O'Brien, Jennifer Klima, Amanda M Termuhlen, et al.
Seminars in Oncology|October 20, 2009
Lymphoma in adolescents and young adultsSamantha M Jaglowski, Erica Linden, Amanda M Termuhlen, et al.
Pediatric Transplantation|October 13, 2006
Autologous hematopoietic stem cell transplant with melphalan and thiotepa is safe and feasible in pediatric patients with low normalized glomerular filtration rateAmanda M Termuhlen, Alfred Grovas, Kathryn Klopfenstein, et al.
Pageof 4